RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+4.47%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$563M
AUM Growth
+$563M
(+12%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
30.6%
Holding
102
New
10
Increased
33
Reduced
31
Closed
5
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$13.1M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.9M |
| 3 |
Biogen
BIIB
|
$10.2M |
| 4 |
CELG
Celgene Corp
CELG
|
$7.79M |
| 5 |
ENDP
Endo International plc
ENDP
|
$5.85M |
Top Sells
| 1 |
Alkermes
ALKS
|
$11.6M |
| 2 |
STJ
St Jude Medical
STJ
|
$9.9M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.45M |
| 4 |
Labcorp
LH
|
$3.91M |
| 5 |
Perrigo
PRGO
|
$3.72M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Financials | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pacira BioSciences
PCRX
$1.22B
| – | – |
-40,000
| Closed | -$2.12M |
|
102
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-64,000
| Closed | -$2.59M |
|